EPIT Stock Overview
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Epitomee Medical Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪2.96 |
52 Week High | ₪19.48 |
52 Week Low | ₪2.90 |
Beta | 0 |
1 Month Change | -6.22% |
3 Month Change | -24.19% |
1 Year Change | -78.69% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -92.78% |
Recent News & Updates
Recent updates
Shareholder Returns
EPIT | IL Medical Equipment | IL Market | |
---|---|---|---|
7D | -0.6% | -2.0% | -3.1% |
1Y | -78.7% | 3.5% | 9.5% |
Return vs Industry: EPIT underperformed the IL Medical Equipment industry which returned 7.4% over the past year.
Return vs Market: EPIT underperformed the IL Market which returned 10% over the past year.
Price Volatility
EPIT volatility | |
---|---|
EPIT Average Weekly Movement | 4.9% |
Medical Equipment Industry Average Movement | 4.9% |
Market Average Movement | 4.4% |
10% most volatile stocks in IL Market | 8.0% |
10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: EPIT's share price has been volatile over the past 3 months.
Volatility Over Time: EPIT's weekly volatility has decreased from 19% to 5% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | n/a | Dan Hashimshony | www.epitomeemedical.com |
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule.
Epitomee Medical Ltd Fundamentals Summary
EPIT fundamental statistics | |
---|---|
Market cap | ₪87.07m |
Earnings (TTM) | ₪0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs EPIT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EPIT income statement (TTM) | |
---|---|
Revenue | ₪0 |
Cost of Revenue | ₪0 |
Gross Profit | ₪0 |
Other Expenses | ₪0 |
Earnings | ₪0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did EPIT perform over the long term?
See historical performance and comparison